Monopar Therapeutics Stock Predictions

Why Trump Could Send These 3 Stocks Soaring

According to legendary investor Louis Navellier, these three "Made in America" stocks are set to benefit from this coming boom.

Sell

MNPR
Monopar Therapeutics

Last Price:

$40.64

Seasonality Move:

62.15%

7 Day Trial

ALL ACCESS PASS

$ 7

Legendary Investor: "It's Time to Buy These 3 Made-in-America Stocks"

He's now recommending these Three Stocks for Trump's New Industrial Boom.

Monopar Therapeutics Stock Forecast

Over the next 52 weeks, Monopar Therapeutics has on average historically risen by 182.6% based on the past 5 years of stock performance.
Monopar Therapeutics has risen higher in 1 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 20%
Is Monopar Therapeutics Stock Undervalued?

The current Monopar Therapeutics [MNPR] share price is $40.45. The Score for MNPR is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
MNPR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Monopar Therapeutics Stock Go Up Next Year?

Over the next 52 weeks, Monopar Therapeutics has on average historically risen by 182.6% based on the past 5 years of stock performance.

Monopar Therapeutics Stock Rating

Sell

Monopar Therapeutics (MNPR) is a Sell

Is Monopar Therapeutics overpriced?

Monopar Therapeutics has risen higher in 1 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 20%

Monopar Therapeutics Stock Price History

Is MNPR stock going to rise?

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MNPR is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

monopartx.com

52-Week Data

52-Week High:

54.30

52-Week Low:

1.72

Prediction Charts

Market Cap:

247.4M

Price in USD:

40.45

Volume:

17.6K

Beta:

1.23

Technical Analysis

SMA50:

37.69

SMA100:

37.73

SMA200:

32.35

52-Wk Change:

1226.23%

Stock Predictions

Is Monopar Therapeutics stock public?

Yes, Monopar Therapeutics is a publicly traded company.
What is the Monopar Therapeutics stock quote today?

The Monopar Therapeutics stock price is 40.45 USD today.
How to buy Monopar Therapeutics stock online?

You can buy Monopar Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Jul-17	40.79	47.25	47.28	40.79
Jul-18	47.76	46.48	50.14	46.48
Jul-21	47.10	46.43	48.35	45.11
Jul-22	45.52	45.22	45.54	44.26
Jul-23	45.20	46.87	46.91	45.20
Jul-24	46.87	46.82	47.52	45.20
Jul-25	47.00	44.97	47.00	44.37
Jul-28	44.40	43.40	44.58	43.01
Jul-29	44.36	43.03	44.36	41.50
Jul-30	44.34	42.66	44.34	41.67
Jul-31	42.65	41.18	42.65	40.71
Aug-1	40.01	40.69	41.60	39.61
Aug-4	40.54	41.75	42.21	39.92
Aug-5	42.50	40.45	42.50	39.24

Monopar Therapeutics Earnings

Monopar Therapeutics Earnings Report: Per Share Monopar Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Monopar Therapeutics Forecast Revenue Growth

Monopar Therapeutics Stock Analysis: Historical quarterly revenues per share for Monopar Therapeutics and historical quarterly revenue growth:

Analysts estimate an earnings decrease this quarter of $0.66 per share, a decrease next quarter of $0.13 per share, a decrease this year of $0.26 per share, and a decrease next year of $0.48 per share.

* Monopar Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.